83 results
Page 2 of 5
8-K
EX-99.1
8tllnt
14 Aug 23
NeuroOne® Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
4:15pm
8-K
EX-99.2
mi7v7 pome2bjigapwxi
27 Jul 23
NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock
4:02pm
8-K
EX-99.1
2w9q5 wk9
27 Jul 23
NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock
4:02pm
424B5
yz2wig3ju ygst
26 Jul 23
Prospectus supplement for primary offering
4:24pm
424B5
oir696em
24 Jul 23
Prospectus supplement for primary offering
4:43pm
8-K
EX-99.1
81is439
11 May 23
NeuroOne® Reports Second Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
4:16pm
8-K
EX-99.1
v0dvemz4n
22 Dec 22
NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2022 Financial Results
9:11am
424B5
n2ropeh8
22 Dec 22
Prospectus supplement for primary offering
6:43am
8-K
EX-99.1
n7u9shyg6ji0se1a 5m
25 Oct 22
NeuroOne® Receives FDA 510(k) Clearance to Market its Evo® sEEG System for Less than 30 Day Use
9:19am
8-K
EX-99.1
eqs2vf1d
14 Sep 22
Regulation FD Disclosure
8:30am
8-K
EX-99.1
5c0ia
11 Aug 22
NeuroOne® Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
4:49pm
8-K
EX-99.1
58aq1hql
3 Aug 22
NeuroOne® Announces $3.5 Million Accelerated Milestone Payment from Zimmer Biomet for Evo® sEEG Electrode
9:34am
8-K
EX-99.1
xrnlp 1dzgn
2 Jun 22
NeuroOne® Issues Letter to Stockholders in Connection With 2022 Annual Meeting of Stockholders
4:05pm
8-K
EX-99.1
gjhkne4 ra
16 May 22
NeuroOne Provides Evo® sEEG Update
4:38pm